Comparison of Billroth I and Billroth II reconstructions after laparoscopy-assisted distal gastrectomy: a retrospective analysis of large-scale multicenter results from Korea
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011
52
A prospective, randomized trial of esophageal submucosal tunnel closure with a stent versus no closure to secure a transesophageal natural orifice transluminal endoscopic surgery access site
김민찬, Brian G. Turner, Denise W. Gee, Abdulmetin Dursun, Mari Mino-Kenudson, Edward S. Huang, Patricia Sylla, David W. Rattner, William R. Brugge
GASTROINTESTINAL ENDOSCOPY, 2011
53
Stent placement provides safe esophageal closure in thoracic NOTES(TM) procedures
김민찬, Brian G. Turner, Sevdenur Cizginer, Mari Mino-Kenudson, Richard W. Ducharm, Vihar C. Surti, Patricia Sylla, David W. Rattner, William R. Brugge, Denise W. Gee
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2011
54
Clinicopathologic significance of ERCC1, thymidylate synthase and glutathione S-transferase P1 expression for advanced gastric cancer patients receiving adjuvant 5-FU and cisplatin chemotherapy
김민찬, 김기한, 권혁찬, 오성용, 김성현, 이수이, 권경아, 장진석, 김수진, 김효진
BIOMARKERS, 2011
55
Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection
김민찬, 권혁찬, 김기한, 장진석, 오성용, 김성현, 권경아, 이수이, 이형식, 김효진
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010
56
Short Rare MUC6 Minisatellites-5 Alleles Influence Susceptibility to Gastric Carcinoma by Regulating Gene Expression
김민찬, 임선희, 권정아, 이상엽, 안은경, 설소영, 김수진, 김승일, 추인선
HUMAN MUTATION, 2010
57
Expression of VEGF, EGFR, and IL-6 in Gastric Adenomas and Adenocarcinomas by Endoscopic Submucosal Dissection
김민찬, 최석렬, 이신애, 장진석, 이종훈, 노명환, 정진숙, 김수진, 김상옥
DIGESTIVE DISEASES AND SCIENCES, 2010
58
Recurrence Following Laparoscopy-Assisted Gastrectomy for Gastric Cancer: A Multicenter Retrospective Analysis of 1,417 Patients
김민찬, 송재원, 이혁준, 조규석, 한상욱, 류승완, 김욱, 송교영, 김형호, 형우진
ANNALS OF SURGICAL ONCOLOGY, 2010
59
A Phase II Study of Irinotecan With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFIRI) as First Line Therapy For Patients With Recurrent or Metastatic Gastric Cancer